Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
61.40 +0.77    +1.27%
16:52:05 - Delayed Data. Currency in EUR ( Disclaimer )
  • Volume: 4,966
  • Bid/Ask: 61.46 / 61.53
  • Day's Range: 60.40 - 61.61
Type:  Equity
Market:  Germany
ISIN:  US3755581036 
S/N:  885823
Gilead 61.40 +0.77 +1.27%

GILD Recent Sentiments

 
User's sentiments regarding Gilead shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect GILD shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for Gilead.
Start Date Username Call Open Rate End Date Chg. %
Nov 15, 2023 Bernd Pohlmann   69.50 Nov 30, 2023 @ 68.60 -1.29%
Dec 29, 2021 Werner Ehmke   64.95 Jan 21, 2022 @ 60.50 -6.85%
Nov 09, 2021 Bernd Pohlmann   56.67 Nov 15, 2021 @ 59.38 +4.78%
Sep 10, 2021 Hans WURST   60.21 Oct 01, 2021 @ 59.34 -1.44%
Aug 11, 2021 Michael Lorenz   59.60 Sep 03, 2021 @ 60.63 +1.73%
Apr 13, 2021 Bernd Pohlmann   54.23 Apr 19, 2021 @ 54.74 +0.94%
Jan 19, 2021 Jörg Humke   55.34 Feb 12, 2021 @ 55.17 -0.31%
Jan 19, 2021 Bastiaan Bos   55.80 Feb 12, 2021 @ 55.17 -1.13%
Jan 11, 2021 Matthias Winkler   52.94 Feb 05, 2021 @ 56.64 +6.99%
Dec 23, 2020 Bastiaan Bos   46.55 Jan 15, 2021 @ 52.39 +12.55%
Nov 18, 2020 Bastiaan Bos   51.22 Dec 11, 2020 @ 50.12 -2.15%
Oct 19, 2020 Bastiaan Bos   52.45 Nov 13, 2020 @ 51.32 -2.15%
Sep 30, 2020 Mike Lorenzo   52.64 Oct 23, 2020 @ 51.26 -2.62%
Sep 18, 2020 vp pvv   55.02 Oct 09, 2020 @ 53.93 -1.98%
Sep 14, 2020 Martin Riess   56.32 Oct 09, 2020 @ 53.93 -4.24%
Sep 02, 2020 Bastiaan Bos   56.22 Sep 25, 2020 @ 53.51 -4.82%
Aug 19, 2020 Kate Frankfurt   54.90 Sep 11, 2020 @ 55.29 -0.71%
Jul 31, 2020 Klaus Henter   59.13 Aug 21, 2020 @ 56.45 +4.53%
Jul 30, 2020 Teiminger Bote   62.47 Aug 21, 2020 @ 56.45 -9.64%
Jun 29, 2020 Martin Riess   66.28 Jul 24, 2020 @ 63.10 -4.80%
Jun 02, 2020 Bastiaan Bos   65.48 Jun 26, 2020 @ 66.44 +1.47%
May 25, 2020 Dmitry Ivanov   69.31 Jun 19, 2020 @ 68.68 -0.91%
May 25, 2020 Can On   69.26 Jun 02, 2020 @ 66.72 +3.67%
May 21, 2020 Anica Voß   67.03 Jun 12, 2020 @ 65.14 -2.82%
May 12, 2020 Robin Mendetzki   74.89 Jun 05, 2020 @ 67.89 -9.35%
May 11, 2020 Marco Dormann   72.79 Jun 05, 2020 @ 67.89 -6.73%
May 07, 2020 Martin Riess   72.46 May 29, 2020 @ 70.25 -3.05%
May 06, 2020 Dominik Hehe   73.64 May 29, 2020 @ 70.25 -4.60%
May 05, 2020 Bastiaan Bos   73.60 May 29, 2020 @ 70.25 -4.55%
May 04, 2020 Martin Es   74.99 May 29, 2020 @ 70.25 +6.32%
May 04, 2020 Ralf Rothes   76.49 May 29, 2020 @ 70.25 -8.16%
May 04, 2020 Dominik Hehe   76.84 May 05, 2020 @ 73.17 -4.78%
Apr 30, 2020 Volker Leclerque   76.33 May 22, 2020 @ 67.14 -12.04%
Apr 29, 2020 Hermann Albrecht   76.38 Apr 30, 2020 @ 76.48 +0.13%
Apr 29, 2020 Andre Bartels   77.48 May 22, 2020 @ 67.14 +13.35%
Apr 29, 2020 Combat Schnecke   78.79 May 22, 2020 @ 67.14 -14.79%
Apr 27, 2020 Piotr Jagiello   72.72 Apr 27, 2020 @ 72.56 -0.22%
Apr 17, 2020 Christian Göbl   78.69 May 08, 2020 @ 71.50 -9.14%
Apr 17, 2020 Ol Ma   83.79 May 08, 2020 @ 71.50 -14.67%
Apr 17, 2020 Michael Mayer   83.99 May 08, 2020 @ 71.50 -14.87%
Apr 17, 2020 adam Farart   83.99 May 08, 2020 @ 71.50 -14.87%
Apr 17, 2020 CHRIS GAMEZ   84.49 May 08, 2020 @ 71.50 -15.37%
Apr 08, 2020 Martin Riess   68.48 May 01, 2020 @ 76.48 +11.68%
Mar 19, 2020 Christian Gruber   74.00 Apr 10, 2020 @ 67.27 -9.09%
Mar 12, 2020 Hans WURST   62.31 Mar 12, 2020 @ 62.78 +0.75%
Mar 10, 2020 Martin Riess   67.25 Apr 03, 2020 @ 72.21 +7.38%
Feb 03, 2020 Алексей Луконенко   61.07 Feb 21, 2020 @ 64.20 +5.13%
Oct 24, 2018 ziya yılmaz   62.95 Nov 01, 2018 @ 63.38 +0.68%
Aug 31, 2017 Hermann Albrecht   67.71 Aug 31, 2017 @ 70.00 +3.38%
Aug 31, 2017 Hermann Albrecht   69.00 Aug 31, 2017 @ 69.24 +0.35%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Price Commentary

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job GILD. bullish move forward
Ashraf Elgendy
Ashraf Elgendy Mar 07, 2021 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
RM RM
RM RM Mar 01, 2021 21:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up Again
Ken Laing
Ken Laing Oct 23, 2020 18:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up before the big rise coming next week
Iggy Maldon
Iggy Maldon Jul 30, 2020 20:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Classic pump n’ dump. What a shambles
RM RM
RM RM May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will reach above 95
Chili Daug
Chili Daug May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when? hahah
SAGAR AGARWAL
SAGAR AGARWAL May 15, 2020 14:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to accumulate.
Khizer Malik
Khizer Malik May 14, 2020 11:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
Willy Chin
Willy Chin Apr 23, 2020 18:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
High chance to be trading above 90, good long stock
Viktor Veselý
Viktor Veselý Apr 12, 2020 7:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email